← Leaderboards
Isaac Kirubakaran Sundar
Roswell Park Cancer Institute Corp
$5,058,662
Attributed
$5,058,662
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.1M · FY2018–23$2M$1.5M$1M$500K$0
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$5,058,662 · 2
By mechanism
U54$3,113,512 · 1
R01$1,945,150 · 1
Top collaborators
No co-investigators on record.
Most similar at Roswell Park Cancer Institute Corp
Same institution · by research overlap
- Maciej Lukasz Goniewicz$7,908,117
- Richard J O'Connor$21,371,886
- Amanda J Quisenberry$727,681
- Maansi Bansal-Travers$2,183,141
- Yasmin Thanavala$4,506,996
Others in their field
Other Emerging Leaders on “Response”
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$195,683,539
- Kimberly Smith · Ppd Development Lp$115,671,664
- Paul F Gallagher · Woods Hole Oceanographic Institution$92,619,872
- Kevin Urdahl · Seattle Children'S Hospital$84,741,409
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$71,439,892
- Ted Ross · University Of Georgia$70,992,558
Research focus
ResponseAffectMediatingTissuesIn VivoEpithelial CellsExposure ToLiquid SubstancePlasmaTranscriptome SequencingMouse ModelBiologicalIn VitroCellsAirway EpitheliumCell TypeAdrenal Cortex HormonesBindingCell PhysiologyCircadianAllergic Airway InflammationAttenuatedAllergic ResponseAgonist
Grant awards (11)
Nuclear Receptor REV-ERB alpha Role in the Pathophysiology of Allergic Asthma$387,824
R01 · FY2023 · HL · contact PI
Core D: Biomarkers, Genomics & Epigenomics Core$627,534
U54 · FY2022 · CA · contact PI
Nuclear Receptor REV-ERB alpha Role in the Pathophysiology of Allergic Asthma$387,791
R01 · FY2022 · HL · contact PI
Core D: Biomarkers, Genomics & Epigenomics Core$626,991
U54 · FY2021 · CA · contact PI
Nuclear Receptor REV-ERB alpha Role in the Pathophysiology of Allergic Asthma$385,375
R01 · FY2021 · HL · contact PI
Core D: Biomarkers, Genomics & Epigenomics Core$627,186
U54 · FY2020 · CA · contact PI
Nuclear Receptor REV-ERB alpha Role in the Pathophysiology of Allergic Asthma$311,040
R01 · FY2020 · HL · contact PI
Nuclear Receptor REV-ERB alpha Role in the Pathophysiology of Allergic Asthma$77,902
R01 · FY2020 · HL · contact PI
Core D: Biomarkers, Genomics & Epigenomics Core$685,976
U54 · FY2019 · CA · contact PI
Nuclear Receptor REV-ERB alpha Role in the Pathophysiology of Allergic Asthma$395,218
R01 · FY2019 · HL · contact PI
Core D: Biomarkers, Genomics & Epigenomics Core$545,825
U54 · FY2018 · CA · contact PI